ROS-major mediators of extracellular matrix remodeling during tumor progression

Food and Chemical Toxicology

Volumn 61, Issue , 2013, Pages 178-186

  Nikitovic, Dragana ^a   Corsini, Emanuela ^b   Kouretas, Dimitrios ^c   Tsatsakis, Aristidis ^d   Tzanakakis, George ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF THESSALY   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

Extracellular matrix; Glycosaminoglycans; Matrix metalloproteinases; Metastasis; ROS; Tumor

Indexed keywords

CYCLOOXYGENASE 2; GELATINASE A; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; PROTEOGLYCAN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL COMPOSITION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; ENZYME DEGRADATION; ENZYME LOCALIZATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR SPACE; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; OXIDATIVE STRESS; STROMA; TUMOR CELL; TUMOR ESCAPE; TUMOR GROWTH; TUMOR INVASION; TUMOR MICROENVIRONMENT;

CHONDROITIN SULFATE; CS; DERMATAN SULFATE; DS; ECM; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GAG; GLYCOSAMINOGLYCANS; HA; HEPARAN SULFATE; HS; HYALURONAN; KERATAN SULFATE; KS; MATRIX METALLOPROTEINASES; METASTASIS; REACTIVE OXYGEN SPECIES; ROS; TUMOR;

ANIMALS; ENZYMES; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; NEOPLASMS; OXIDATIVE STRESS; PROTEOGLYCANS; REACTIVE OXYGEN SPECIES; STROMAL CELLS;

EID: 84888840798     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.06.013     Document Type: Article

References (130)

1. Afratis N., Nikitovic D., Tsegenidis T., Karousou E., Theocharis A.D., Pavão M.S., Tzanakakis G.N., Karamanos N.K. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J. 2012, 279:1177-1197.
2. Agren U.M., Tammi R.H., Tammi M.I. Reactive oxygen species contribute to epidermal hyaluronan catabolism in human skin organ culture. Free Radic. Biol. Med. 1997, 23:996-1001.
3. Babior B.M. The leukocyte NADPH oxidase. Isr. Med. Assoc. J. 2002, 4:1023-1024.
4. Baranwal S., Alahari S.K. Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun. 2009, 384:6-11.
5. Ben Mahdi M.H., Andrieu V., Pasquier C. Focal adhesion kinase regulation by oxidative stress in different cell types. IUBMB Life. 2000, 50:291-299.
6. Berdiaki A., Tsatsakis A., Katonis P., Karamanos N.K., Tzanakakis G.N. BFGF induces changes in hyaluronan synthase and hyaluronidase isoform expression and modulates the migration capacity of fibrosarcoma cells. Biochim. Biophys. Acta 2009, 1790:1258-1265.
7. Berdiaki A., Nikitovic D., Tsatsakis A., Katonis P., Karamanos N.K., Tzanakakis G.N. Parathyroid hormone (PTH) peptides through the regulation of hyaluronan metabolism affect osteosarcoma cell migration. IUBMB Life. 2010, 62:377-386.
8. Bertout J.A., Patel S.A., Simon M.C. The impact of O2 availability on human cancer. Nat. Rev. Cancer. 2008, 8:967-975.
9. Bhowmick N.A., Neilson E.G., Moses H.L. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332-337.
10. Blasi F. Urokinase and Urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 1993, 15:105-111.
11. Block K., Gorin Y. Aiding and abetting roles of NOX oxidases in cellular transformation. Nat. Rev. Cancer. 2012, 12:627-637.
12. Brieger K., Schiavone S., Miller F.J., Krause K.H. Reactive oxygen species: from health to disease. Swiss Med. Wkly. 2012, 142:w13659.
13. Brooks S.A., Lomax-Browne H.J., Carter T.M., Kinch C.E., Hall D.M. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010, 112:3-25.
14. Broom O.J., Massoumi R., Sjölander A. Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells. J. Cell Physiol. 2008, 209:950-958.
15. Chaffer C.l., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
16. Chiarugi P. Reactive oxygen species as mediators of cell adhesion. Ital. J. Biochem. 2003, 52:28-32.
17. Chiu W.T., Shen S.C., Chow J.M., Lin C.W., Shia L.T., Chen Y.C. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation. Neurobiol. Dis. 2010, 37:118-129.
18. Cirri P., Chiarugi P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 2012, 31:195-208.
19. Corsini, E., Galbiati, V., Nikitovic, D., Tsatsakis, A.M., 2013. Role of oxidative stress in chemical allergens induced skin cells activation. Food Chem. Toxicol. doi: pii: S0278-6915(13)00147-6 (E-pub).
20. Csoka A.B., Frost G.I., Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001, 20:499-508.
21. Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 1995, 369:131-135.
22. Das, T.P., Suman, S., Damodaran, C., 2013. Reactive oxygen species generation inhibits epithelial-mesenchymal transition and promotes growth arrest in prostate cancer cells. Mol. Carcinog. http://dx.doi.org/10.1002/mc.22014. [Epub ahead of print].
23. De Larco J.E., Wuertz B.R., Furcht L.T. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin. Cancer Res. 2004, 10:4895-4900.
24. Dedes P.G., Gialeli Ch., Tsonis A.I., Kanakis I., Theocharis A.D., Kletsas D., Tzanakakis G.N., Karamanos N.K. Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid. Biochim. Biophys. Acta 2012, 1820:1926-1939.
25. Díaz B., Courtneidge S.A. Redox signaling at invasive microdomains in cancer cells. Free Rad. Biol. Med. 2012, 52:247-256.
26. Dreher D., Junod A.F. Role of oxygen free radicals in cancer development. Eur. J. Cancer. 1996, 32A:30-38.
27. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
28. Ferraro D., Corso S., Fasano E., Panieri E., Santangelo R., Borrello S., Giordano S., Pani G., Galeotti T. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 2006, 25:3689-3698.
29. Fiore E., Fusco C., Romero P., Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 2002, 21:5213-5223.
30. Ghael D., Mileva M., Dweck H.S., Rosenfeld L. The nitric oxide donor S-nitroso-N-acetyl-D, L-penicillamine degrades heparan sulfate and heparin. Biochem. Mol. Biol. Int. 1997, 43:183-188.
31. Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011, 278:16-27.
32. Gialeli C., Theocharis A.D., Kletsas D., Tzanakakis G.N., Karamanos N.K. Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab. Invest. New Drugs 2013, 31:516-524.
33. Gianni D., Taulet N., DerMardirossian C., Bokoch G.M. C-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells. Mol. Biol. Cell. 2010, 23:4287-4298.
34. Gianni D., Taulet N., Zhang H., DerMardirossian C., Kister J., Martinez L., Roush W.R., Brown S.J., Bokoch G.M., Rosen H. A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells. ACS Chem. Biol. 2010, 5:981-993.
35. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxidants Redox Signal. 2012, 16:1248-1263.
36. Gorelik L., Flavell R.A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat. Med. 2001, 7:1118-1122.
37. Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J 2001, 353:411-416.
38. Hassan M.S., Mileva M.M., Dweck H.S., Rosenfeld L. Nitric oxide products degrade chondroitin sulfates. Nitric Oxide 1998, 360-365.
39. Herszényi L., Lakatos G., Hritz I., Varga M.Z., Cierny G., Tulassay Z. The role of inflammation and proteinases in tumor progression. Dig Dis. 2012, 30:249-254.
40. Ho B.Y., Wu Y.M., Chang K.J., Pan T.M. Dimerumic acid inhibits SW620 cell invasion by attenuating H[U+2082]O[U+2082]-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner. Int. J. Biol. Sci. 2011, 7:869-880.
41. Houghton A.M. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 2010, 9:1732-1737.
42. Hrabarova E., Juranek I., Soltes L. Pro-oxidative effect of peroxynitrite regarding biological systems: a special focus on high-molar-mass hyaluronan degradation. Gen. Physiol. Biophys. 2011, 30:223-238.
43. Hung W.Y., Huang K.H., Wu C.W., Chi C.W., Kao H.L., Li A.F., Yin P.H., Lee H.C. Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced β5-integrin expression in human gastric cancer SC-M1 cells. Biochim. Biophys. Acta 2012, 1820:1102-1110.
44. Hu C.T., Wu J.R., Cheng C.C., Wang S., Wang H.T., Lee M.C., Wang L.J., Pan S.M., Chang T.Y., Wu W.S. Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2. Clin Exp Metastasis. 2011, 28:851-863.
45. Hynes R.O. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219.
46. Inumaru J., Nagano O., Takahashi E., Ishimoto T., Nakamura S., Suzuki Y., Niwa S., Umezawa K., Tanihara H., Saya H. Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells 2009, 14:703-716.
47. Iyer A., Brown L. Is mycophenolate more than just an immunosuppressant? An overview. Indian J. Biochem. Biophys. 2009, 46:25-30.
48. Jiang D., Liang J., Noble P.W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91:221-264.
49. Josson S., Matsuoka Y., Chung L.W., Zhau H.E., Wang R. Tumor-stroma co-evolution in prostate cancer progression and metastasis. Semin. Cell Dev. Biol. 2010, 21:26-32.
50. Karihtala P., Soini Y., Auvinen P., Tammi R., Tammi M., Kosma V.M. Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation. J. Histochem. Cytochem. 2007, 55:1191-1198.
51. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenviroment. Cell 2010, 141:52-67.
52. Kheradmand F., Werner E., Tremble P., Symons M., Werb Z. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science 1998, 280:898-902.
53. Kim M.H., Cho H.S., Jung M., Hong M.H., Lee S.K., Shin B.A., Ahn B.W., Jung Y.D. Extracellular signal-regulated kinase and AP-1 pathways are involved in reactive oxygen species-induced urokinase plasminogen activator receptor expression in human gastric cancer cells. Int. J. Oncol. 2005, 26:1669-1674.
54. Kim K.H., Cho Y.S., Park J.M., Yoon S.O., Kim K.W., Chung A.S. Pro-MMP-2 activation by the PPAR gamma agonist, ciglitazone, induces cell invasion through the generation of ROS and the activation of ERK. FEBS Lett. 2007, 17:3303-3310.
55. Kim M.H., Yoo H.S., Kim M.Y., Jang H.J., Baek M.K., Kim H.R., Kim K.K., Shin B.A., Ahn B.W., Jung Y.D. Helicobacter pylori stimulates urokinase plasminogen activator receptor expression and cell invasiveness through reactive oxygen species and NF-kappaB signaling in human gastric carcinoma cells. Int. J. Mol. Med. 2007, 19:689-697.
56. Kim E.Y., Seo J.M., Cho K.J., Kim J.H. Ras induced invasion and metastasis are regulated by a leukotriene B4 receptor BLT2-linked pathway. Oncogene 2010, 29:1167-1178.
57. Kim M.J., Kim D.H., Na H.K., Surh Y.J. TNF-α induces expression of urokinase-type plasminogen activator and β-catenin activation through generation of ROS in human breast epithelial cells. Biochem. Pharmacol. 2010, 80:2092-2100.
58. Klaunig J.E., Kamendulis L.M. The role of oxidative stress in carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 2004, 44:239-267.
59. Klaunig J.E., Xu Y., Bachowski S., Jiang J. Free-radical oxygen-induced changes in chemical carcinogenesis. Free Radical Toxicology 1997, 375-400. Taylor & Francis, London. K.B. Wallace (Ed.).
60. Kouvidi K., Berdiaki A., Nikitovic D., Katonis P., Afratis N., Hascall V.C., Karamanos N.K., Tzanakakis G.N. Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J. Biol. Chem. 2011, 286.
61. Krause K.H. Aging: a revisited theory based on free radicals generated by NOX family NADPH oxidases. Exp. Gerontol. 2007, 42:256-262.
62. Kunisada M., Yogianti F., Sakumi K., Ono R., Nakabeppu Y., Nishigori C. Increased expression of versican in the inflammatory response to UVB- and reactive oxygen species-induced skin tumorigenesis. Am. J. Pathol. 2011, 179:3056-3065.
63. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189.
64. Lee J., Lim K.T. Inhibitory effect of phytoglycoprotein (38 kDa) on expression of matrix metalloproteinase-9 in 12-O-tetradecanoylphorbol-13-acetate-treated HepG2 cells. Naunyn. Schmiedebergs Arch. Pharmacol. 2011, 384:185-196.
65. Lee K.H., Kim S.W., Kim J.R. Reactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells. J. Exp. Clin. Cancer Res. 2009, 28:73.
66. Lennon F.E., Singleton P.A. Hyaluronan regulation of vascular integrity. Am. J. Cardiovasc. Dis. 2011, 1:200-213.
67. Lim S.O., Gu J.M., Kim M.S., Kim H.S., Park Y.N., Park C.K., Cho J.W., Park Y.M., Jung G. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008, 135:2128-2140.
68. Lim S.K., Choi Y.W., Lim I.K., Park T.J. BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. Clin. Exp. Metastasis. 2012, 29:901-913.
69. Lisanti M.P., Martinez-Outschoorn U.E., Chiavarina B., Pavlides S., Whitaker-Menezes D., Tsirigos A., Witkiewicz A., Lin Z., Balliet R., Howell A., Sotgia F. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment. Cancer Biol. Ther. 2010, 10:537-542.
70. Liu F., Gomez Garcia A.M., Meyskens F.L. NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells. J. Invest. Dermatol. 2012, 132:2033-2041.
71. Loft S., Poulsen H.E. Cancer risk and oxidative DNA damagein man. J. Mol. Med.-JMM. 1996, 74:297-312.
72. Mantovani A. Cancer: inflaming metastasis. Nat. Rev. Cancer 2009, 457:36-37.
73. Mao, Y., Keller, E.T., Garfield, D.H., Shen, K., Wang, J., 2012. Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev. (E-pub).
74. Meyer T., Hart I.R. Mechanisms of tumour metastasis. Eur. J. Cancer 1998, 34:214-221.
75. Monzon M.E., Freigen N., Schmid N., Falcon N.S., Campos M., Casalino-Matsuda S.M. Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation. J. Biol. Chem. 2010, 285:26126-26134.
76. Morgan, D., Cherny, V.Y., Finnegan, A., Bollinger, J., Gelb M.H., DeCoursey, T.E., 2007. Sustained activation of proton channels and NADPH oxidase in human eosinophils and murine granulocytes requires PKC but not cPLA2 alpha activity. J. Physiol. 579, 327-344.
77. Mori K., Shibanuma M., Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res. 2004, 64:7464-7472.
78. Mytar B., Siedlar M., Woloszyn M., Colizzi V., Zembala M. Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation: the essential role of hyaluronan. Int. J. Cancer 2001, 94:727-732.
79. Nagaprashantha L.D., Vatsyayan R., Lelsani P.C., Awasthi S., Singhal S.S. The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int. J Cancer 2011, 128:743-752.
80. Nash G.F., Turner L.F., Scully M.F., Kakkar A.K. Platelets and cancer. Lancet Oncol. 2002, 3:425-430.
81. Nelson K.K., Ranganathan A.C., Mansouri J., Rodriguez A.M., Providence K.M., Rutter J.L., Pumiglia K., Bennett J.A., Melendez J.A. Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasis. Clin. Cancer Res. 2003, 9:424-432.
82. Nelson C.M., Khauv D., Bissell M.J., Radisky D.C. Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J. Cell. Biochem. 2008, 105:25-33.
83. Nguyen H.L., Zucker S., Zarrabi K., Kadam P., Schmidt C., Cao J. Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase. Mol. Cancer Res. 2011, 9:1305-1318.
84. Nikitovic D., Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J. Biol. Chem. 1996, 271:19180-19185.
85. Nikitovic D., Holmgren A., Spyrou G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 1998, 242:109-112.
86. Nikitovic D., Zafeiropoulos A., Katonis P., Tsatsakis A., Theocharis A.D., Karamanos N.K., Tzanakakis G.N. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells. IUBMB Life. 2006, 58:47-53.
87. Nikitovic D., Aggelidakis J., Young M.F., Iozzo R.V., Karamanos N.K., Tzanakakis G.N. The biology of small leucine-rich proteoglycans in bone pathophysiology. J. Biol. Chem. 2012, 41:33926-33933.
88. Nikitovic D., Chatzainikolaoum G., Tsiaoussism J., Tsatsakism A., Karamanos N.K., Tzanakakis G.N. Insights into targeting colon cancer cell fate at the level of proteoglycans/glycosaminoglycans. Curr. Med. Chem. 2012, 19:4247-4258.
89. Noble P.W. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol. 2002, 21:25-29.
90. Ostrakhovitch E.A., Li S.S. NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics. Breast Cancer Res. Treat. 2010, 119:773-786.
91. Ozbek S., Balasubramanian P.G., Chiquet-Ehrismann R., Tucker R.P., Adams J.C. The evolution of extracellular matrix. Mol. Biol. Cell. 2010, 21:4300-4305.
92. Padmanabhan J., Gonzalez A.L. The effects of extracellular matrix proteins on neutrophil-endothelial interaction - a roadway to multiple therapeutic opportunities. Yale J. Biol. Med. 2012, 85:167-185.
93. Pani G., Galeotti T., Chiarugi P. Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev. 2010, 29:351-378.
94. Policastro, L.L., Ibanez, I.L., Notcovichm, C., Duran, H.A., Podhajcer, O.L., 2012. The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive oxygen species-targeted gene therapy. Antioxid. Redox. Signal. (E-pub).
95. Pupa S.M., Ménard S., Forti S., Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J. Cell Physiol. 2002, 192:259-267.
96. Roycik M.D., Fang X., Sang Q.X. A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates. Curr. Pharm. Des. 2009, 15:1295-1308.
97. Schluterman M.K., Chapman S.L., Korpanty G., Ozumi K., Fukai T., Yanagisawa H., Brekken R.A. Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS. Dis. Model. Mech. 2010, 3:333-342.
98. Schwartz M.A., DeSimone D.W. Cell adhesion receptors in mechanotransduction. Curr. Opin. Cell Biol. 2008, 20:551-556.
99. Seo J.M., Park S., Kim J.H. Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent upregulation of matrix metalloproteinase 2. J. Biol. Chem. 2012, 287:13840-13849.
100. Sheu B.C., Hsu S.M., Ho H.N., Lien H.C., Huang S.C., Lin R.H. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 2001, 61:237-242.
101. Shimada, K., Nakamura, M., De Velascom, M.A., Tanakam, Mm., Oujim, Ym., Konishi, N., 2009. Syndecan-1, a new target molecule involved in progression of androgen-independent prostate cancer. Cancer Sci. 100, 1248-1254.
102. Singh A., Ramnath R.D., Foster R.R., Wylie E.C., Fridén V., Dasgupta I., Haraldsson B., Welsh G.I., Mathieson P.W., Satchell S.C. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One 2013, 8:2.
103. Sixt M., Kanazawa N., Selg M., Samson T., Roos G., Reinhardt D.P., Pabst R., Lutz M.B., Sorokin L. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005, 22:19-29.
104. Skandalis S.S., Aletras A.J., Gialeli C., Theocharis A.D., Afratis N., Tzanakakis G.N., Karamanos N.K. Targeting the tumor proteasome as a mechanism to control the synthesis and bioactivity of matrix macromolecules. Curr. Mol. Med. 2012, 12:1068-1082.
105. Sorokin L. The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 2010, 7:12-23.
106. Steinbrenner H., Ramos M.C., Stuhlmann D., Mitic D., Sies H., Brenneisen P. Tumor promoter TPA stimulates MMP-9 secretion from human keratinocytes by activation of superoxide-producing NADPH oxidase. Free Radic. 2005, 39:245-253.
107. Stern R. Hyaluronidases in cancer biology. Semin. Cancer Biol. 2008, 18:275-280.
108. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 2006, 85:699-715.
109. Storz P. Reactive oxygen species in tumor progression. Front. Biosci. 2005, 10:1881-1896.
110. Sun C., Wang Z., Zheng Q., Zhang H. Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells. Phytomedicine 2012, 15:355-363.
111. Tatarkova Z., Kuka S., Petráš M., Račay P., Lehotský J., Dobrota D., Kaplan P. Why mitochondria are excellent targets for cancer therapy. Klin. Onkol. 2012, 25:421-426.
112. Teoh M.L., Fitzgerald M.P., Oberley L.W., Domann F.E. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res. 2009, 69:6355-6363.
113. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279:L1005-L1028.
114. Thews O., Lambert C., Kelleher D.K., Biesalski H.K., Vaupel P., Frank J. Impact of reactive oxygen species on the expression of adhesion molecules in vivo. Adv. Exp. Med. Biol. 2009, 645:95-100.
115. Toole B.P., Hascall V. Hyaluronan and tumor growth. Am. J. Pathol. 2002, 161:745-747.
116. Tsai F.C., Wang M.C., Lo J.F., Chou C.M., Lin Y.L. Spatiotemporal dynamics of the biological interface between cancer and the microenvironment: a fractal anomalous diffusion model with microenvironment plasticity. Theor. Biol. Med. Model. 2012, 9:36.
117. Twarock S., Tammi M.I., Savani R.C., Fischer J.W. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J. Biol. Chem. 2010, 285:23276-23284.
118. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
119. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and humandisease. Int. J. Biochem. 2007, 39:44-84.
120. Vesely M.D., Kershaw M.H., Schreiber R.D., Smyth M.J. Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 2011, 29:235-271.
121. Vilar R., Ghael D., Li M., Bhagat D.D., Arrigo L.M., Cowman M.K., Dweck H.S., Rosenfeld L. Nitric oxide degradation of heparin and heparan sulphate. Biochem. J. 1997, 324:473-479.
122. Weaver A.M. Invadopodia: specialized cell structures of cancer invasion. Clin. Exp. Metastasis. 2006, 23:97-105.
123. Weigel P.H., DeAngelis P.L. Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J. Biol. Chem. 2007, 282:36777-36781.
124. Wenk J., Brenneisen P., Wlaschek M., Poswig A., Briviba K., Oberley T.D., Scharffetter-Kochanek K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrixdegrading metalloprotease-1. J. Biol. Chem. 1999, 274:25869-25876.
125. Westermarck J., Kähäri V.M. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J. 1999, 13:781-792.
126. Wu W.S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis. 2006, 25:695-705.
127. Wu Q.D., Wang J.H., Bouchier-Hayes D., Redmond H.P. Neutrophil-induced transmigration of tumour cells treated with tumour-condi-tioned medium is facilitated by granulocyte- macrophage colony-stimulating factor. Eur. J. Surg. 2000, 166:361-366.
128. Wu W.S., Wu J.R., Hu C.T. Signal cross talks for sustained MAPK activation and cell migration: the potential role of reactive oxygen species. Cancer Metastasis Rev. 2008, 27:303-314.
129. Yoon S.O., Park S.J., Yoon S.Y., Yun C.H., Chung A.S. Sustained production of H2O2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-κB pathway. J. Biol. Chem. 2002, 277:30271-30282.
130. Yoon S.O., Park S.J., Yun C.H., Chung A.S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol. 2003, 36:128-137.